By Kiran Mazumdar Shaw The Finance Minister has presented a comprehensive and wide-ranging Budget for FY19, which addresses most of the areas that need focus to ensure sustainable, long-term and equitable growth of the Indian economy. The Union Budget needed to be prudent and forward-looking rather than populist and that is exactly what Finance Minister … Continue reading An Inclusive Budget
By Kiran Mazumdar Shaw, CMD, Biocon 2017 has been an exciting year for science in India. From unheralded incremental innovations to Big Bang headline-grabbing global feats, Indian scientists have done some very important work to push the frontiers of science during the year. India researchers made significant contributions to R&D across a broad spectrum of … Continue reading 2017 – A Landmark Year for Indian Science
By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance
Financial Chronicle: Big Interview: Biocon CMD Kiran Mazumdar-Shaw spoke to FC on a range of topics, including women as entrepreneurs, philanthropy, affordable healthcare, citizen activism etc. Here’s the full version of the interview. As a woman business leader, what are some of the challenges you have encountered in getting to the top and how were … Continue reading Crusader for Affordable Healthcare
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, tells P.B. Jayakumar about the key lessons she has learnt in business life.
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced … Continue reading India To Be A Biotech Hot Spot
Is India Inc.’s new found enthusiasm to have woman board members a reflection of changing mindsets or mere tokenism? Media reports suggest that more than 250 companies appointed women directors on Tuesday to meet the SEBI’s deadline. In fact, many companies have appointed wives, daughters and sisters of promoters and top company executives as directors … Continue reading Why Women on Board Make Smart Business Sense?
A couple of years ago, India celebrated the success of its first Mars mission and I was very excited to see the smiling faces of the women staff of Indian Space Research Organization (ISRO) being splashed all over the media. It was a watershed moment as far as the Indian Space Program is concerned. But, … Continue reading Smart Women Pursuing Smart Science
The new fiscal year promises exciting opportunities for the Indian economy, which is scheduled to bring in a game-changing new reform in the form of the Goods & Services Tax. Expectations of wider economic reforms, new measures to improve the ease of doing business in India and higher infrastructure investments also augur well for the … Continue reading Digital India Can Propel Us to Double-Digit Growth
19th of April is a historic day for India’s space mission. On this day, 42 years ago, ISRO launched the first Indian satellite Aryabhata. Indigenously designed and fabricated in India, Aryabhata was, to paraphrase the legendary Neil Armstrong, “one small step for ISRO, one giant leap for India’s satellite technology.” That India’s maiden satellite was named … Continue reading Delivering Affordable Innovation through Scientific Excellence